TNXP

Tonix Pharmaceuticals Stock Price

0.62
-0.0105 (-1.67%)
0.62

Low
0.51

52 Week Range

High
2.12

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Tonix Pharmaceuticals Holding Corporation TNXP NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0105 -1.67% 0.62 07:01:03
Open Price Low Price High Price Close Price Prev Close
0.6305
Bid Price Ask Price Spread News
0.6201 0.6305 0.0105 - -
Trades Volume Avg Volume 52 Week Range
7 1,419 - 0.51 - 2.12
Last Trade Time Type Quantity Stock Price Currency
06:23:53 formt 100 $ 0.62 USD

Period:

Draw Mode:

Tonix Pharmaceuticals Holding Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 221.66M 357.52M 357.29M $ - $ - -0.75 -2.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 237.44k 1.00%

more financials information »

Tonix Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TNXP Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.68030.6894990.600.633795911,165,363-0.0603-8.86%
1 Month0.66710.77780.600.682290711,541,674-0.0471-7.06%
3 Months1.211.290.600.833746311,545,202-0.59-48.76%
6 Months1.43971.590.601.0612,017,737-0.8197-56.94%
1 Year0.89022.120.511.0817,702,563-0.2702-30.35%
3 Years73.0098.800.39022.339,652,244-72.38-99.15%
5 Years747.60940.000.390220.746,076,656-746.98-99.92%

Tonix Pharmaceuticals Description

Tonix Pharmaceuticals Holding Corp is a clinical-stage pharmaceutical company. The company is engaged in discovering, licensing, acquiring and developing drugs and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes biologics to prevent infectious diseases and small molecules and biologics to treat pain, psychiatric and addiction conditions. While the company is also developing a potential vaccine to protect against the novel coronavirus disease.


Your Recent History
NASDAQ
TNXP
Tonix Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.